Literature DB >> 7969077

The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.

P Banfi1, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta, T A Dragani.   

Abstract

A rabbit antiserum developed against purified rat liver daunorubicin-binding protein of M(r) 54,000 (DNR-BP54) cross-reacted with a mouse protein of the same molecular weight. This protein was expressed in the liver and several other organs of mice. A series of tumors and cell lines tested for the presence of the protein were negative. By immunocytochemistry, we found that DNR-BP54 was abundantly expressed in the cytoplasm of normal hepatocytes but was expressed at much lower levels in urethane-induced mouse liver tumors. By immunoscreening of a mouse liver cDNA library, we cloned the cDNA coding for DNR-BP54 and we found that this protein is aldehyde dehydrogenase-2 (EC 1.2.1.3). This result was confirmed by the dehydrogenase activity found in pure preparations of DNR-BP54 from normal rat and mouse livers, assayed with acetaldehyde as substrate and NAD as cofactor. The enzyme activity was inhibited by daunorubicin. The inhibition was found to be competitive with respect to NAD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969077

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

Review 1.  Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.

Authors:  Byoung-Joon Song; Mohamed A Abdelmegeed; Seong-Ho Yoo; Bong-Jo Kim; Sangmee A Jo; Inho Jo; Kwan-Hoon Moon
Journal:  J Proteomics       Date:  2011-05-15       Impact factor: 4.044

2.  Molecular analysis of two closely related mouse aldehyde dehydrogenase genes: identification of a role for Aldh1, but not Aldh-pb, in the biosynthesis of retinoic acid.

Authors:  L C Hsu; W C Chang; I Hoffmann; G Duester
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  The human aldehyde dehydrogenase 3 gene (ALDH3): identification of a new exon and diverse mRNA isoforms, and functional analysis of the promoter.

Authors:  L C Hsu; W C Chang; C Chang; N Tsukamoto; A Yoshida
Journal:  Gene Expr       Date:  1996

4.  Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation.

Authors:  Kwan-Hoon Moon; Young-Mi Lee; Byoung-Joon Song
Journal:  Free Radic Biol Med       Date:  2009-11-14       Impact factor: 7.376

Review 5.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

Review 6.  Dead enzymes in the aldehyde dehydrogenase gene family: role in drug metabolism and toxicology.

Authors:  Brian C Jackson; David C Thompson; Georgia Charkoftaki; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-11-11       Impact factor: 4.481

Review 7.  Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease.

Authors:  Byoung-Joon Song; Mohamed A Abdelmegeed; Lauren E Henderson; Seong-Ho Yoo; Jie Wan; Vishnudutt Purohit; James P Hardwick; Kwan-Hoon Moon
Journal:  Oxid Med Cell Longev       Date:  2013-04-03       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.